AGP Executive Report

UN Human Rights Watch: Iceland pushed abortion and gender-related recommendations hard at the UN’s Universal Periodic Review in Geneva, issuing over 20% of all sexual orientation and gender identity recommendations and more than 60% of abortion-related ones, while other countries often “noted” rather than backed the criticism. Nordic Health Research: A Norway study presented in diabetes research reports an 11% rise in type 1 diabetes incidence in young children (0.5–5) after rotavirus vaccine rollout, though authors say follow-up analyses suggest the vaccine is probably not the cause. Respiratory Care & Voice: New findings in a Nordic population-based cohort link inhaled corticosteroid use with self-reported voice problems, raising questions about how asthma treatment affects everyday quality of life. Public Health Systems: Iceland is part of the EU-wide JACARDI effort (with Iceland and Norway among participating countries) aimed at reducing cardiovascular disease and diabetes through earlier risk identification and better prevention reach. Mental Health & Safety: A new Iceland true-crime interview series revisits a Reykjavík hotel case involving a mother sentenced to 12 years, with claims tied to illness and plans around suicide.

Diabetes & Vaccines: A Norway study presented to EASD reports a reported 11% rise in type 1 diabetes incidence in children aged 0.5–5 after rapid rotavirus vaccine rollout in 2014, adding to the debate on infection links to autoimmunity. Asthma Care: A Nordic cohort analysis looks at inhaled corticosteroids and self-reported voice problems, highlighting how asthma treatment side effects can affect day-to-day wellbeing. Cardiometabolic Prevention: Iceland is part of JACARDI, an EU-backed joint action (with Norway and Ukraine) aiming to cut cardiovascular disease and diabetes burden through earlier risk detection and better-targeted prevention. Public Health Policy: Iceland submitted a large share of abortion- and gender-related recommendations at a UN human rights review in Geneva, standing out for the volume and focus of its proposals. Health & Environment (PFAS): New reporting flags PFAS “forever chemicals” as a possible skin exposure route, with experts in Iceland warning dermal contact may add to lifetime health risk. Local Health System (Workplace): A tribunal case involving an Iceland supermarket director’s dismissal raises questions about fairness and workplace governance. Global Health Tech: Nezglyal (for early childhood cerebral adrenoleukodystrophy) received EU marketing authorisation under exceptional circumstances, marking the first pharmacological early-intervention option for this disease.

Breast Cancer Awareness: Central Florida communities are hosting October events to support breast cancer patients and survivors, including a Pink Ribbon Gala in Lakeland and a Race2Cure 5K and tribute walk. Nordic Health Research: A Norway study presented to EASD reports an 11% rise in type 1 diabetes incidence in young children (0.5–5) after rotavirus vaccine rollout in 2014, adding to the debate over infection-related risk. Reproductive & Gender Rights (Iceland): Iceland was highlighted for issuing a large share of abortion- and gender-related recommendations during a UN human rights review in Geneva. Public Health & Chemicals: New reporting flags PFAS “forever chemicals” as a possible skin exposure route, not just food and water, with concerns for immune, liver, and skin health. Care & Access (Iceland): A tribunal case involving an Iceland supermarket executive dismissal underscores workplace fairness issues tied to confidentiality and hiring practices. Medical Innovation: EU marketing authorization under exceptional circumstances was granted for Nezglyal for early childhood cerebral adrenoleukodystrophy (cALD), aiming to halt progression earlier. Cardiometabolic Prevention (Iceland in EU project): JACARDI highlights EU-wide work (including Iceland) to reduce cardiovascular disease and diabetes through earlier risk detection and better reach.

Premature-birth survivor story: James Ross, born 11 weeks early and facing life-threatening brain bleeds, now lives with cerebral palsy and neurological migraines—sharing how early support helped him build a full career. Asthma & voice health: A Nordic cohort study links inhaled corticosteroid use with self-reported voice problems, adding nuance to how asthma treatment affects everyday wellbeing. Workplace fairness: An Iceland supermarket tribunal ruled a fired online customer director was unfairly dismissed after concerns tied to her husband’s move to a rival—highlighting stress and fairness in healthcare-adjacent retail roles. Mental health & harm: A new Iceland “true crime” interview revisits the Edition hotel case, where a woman says the family came to Iceland intending to die together. Public health research: Norway data suggests a higher incidence of type 1 diabetes in young children after rotavirus vaccine rollout, with follow-up analyses questioning whether the vaccine is the cause. Cardiometabolic prevention in Iceland: EU-backed JACARDI work includes Iceland in efforts to reduce cardiovascular disease and diabetes through earlier risk detection and better reach. Chemicals & skin exposure: Experts warn PFAS “forever chemicals” may enter the body through skin, not just food and water. Geothermal rights lens: A report compares geothermal benefits in Iceland with community harms in Kenya, focusing on land, livelihoods, and pollution.

Women’s health & mental wellbeing: A new Iceland-related UN human rights review report says Iceland issued the most abortion- and gender-related recommendations, including a large share on sexual orientation and gender identity. Diabetes & vaccines: Norway research presented to EASD reports an 11% rise in type 1 diabetes incidence in young children after rotavirus vaccine rollout—an association that still needs careful interpretation. Cardiometabolic prevention (EU-wide): JACARDI, a joint EU action including Iceland, is pushing earlier cardiovascular disease and diabetes risk detection and better access to prevention across participating countries. Toxic exposure: An Iceland toxicologist highlights PFAS “forever chemicals” as a possible skin exposure route, not just food and water, with potential impacts on immune, liver and skin health. Neurodegenerative disease: The EU granted marketing authorisation for Nezglyal for early intervention in childhood cerebral adrenoleukodystrophy (cALD), the first pharmacological option for this stage. Public health & safety: A case study from Iceland’s National Hospital describes how forensic pathology expertise is being used in a growing local crime-writing boom. Health systems & care access: A UK guidance update outlines visa rules for bereaved foreign nationals after a partner dies, including eligibility tied to Iceland among other countries.

Suicide & justice in Iceland: In a new Sjónvarp Símans Premium true-crime interview, Ming Ting Mancel says she “couldn’t kill myself” and asked her husband to do it; she was sentenced to 12 years for killing her daughter at Reykjavík’s Edition hotel in June 2025, with the case framed around a plan to die together. Cardiometabolic health in Europe (incl. Iceland): JACARDI, a major EU4Health-backed joint action involving 18 EU countries plus Norway, Iceland and Ukraine, is pushing earlier prevention and better reach for cardiovascular disease and diabetes care. Rare disease treatment: The European Commission granted marketing authorisation for Nezglyal (leriglitazone) for early intervention in male childhood cerebral adrenoleukodystrophy (cALD), the first pharmacological option approved in the EU for this stage. Environmental health concern: Iceland toxicologist Oddný Ragnarsdóttir highlights PFAS “forever chemicals” as a possible skin exposure route, linking concerns to immune, liver and metabolic health. Diabetes research: A Norway study presented at EASD reports an 11% rise in type 1 diabetes incidence in young children after rotavirus vaccine rollout, while secondary analyses suggest the vaccine likely isn’t the cause. MS support: Oculis is partnering with the National Multiple Sclerosis Society to back its Campaign to End MS, focusing on vision and accelerating research and access to care. Public health safety: Nunavut health officials report suspected avian flu in 27 harvested birds near Iqaluit and stress basic food and handling precautions.

Diabetes & Vaccines: A Norway study presented at EASD reports an 11% rise in type 1 diabetes incidence in children aged 0.5–5 after rotavirus vaccine rollout in 2014, though researchers say the vaccine is likely not the cause. Cardiometabolic Prevention: EU-backed JACARDI work (including Iceland) is pushing earlier risk detection and better prevention for cardiovascular disease and diabetes across 18 EU countries plus Norway and Ukraine. Rare Disease Treatment: Nezglyal (leriglitazone) has received EU marketing authorisation for early intervention in male childhood cerebral adrenoleukodystrophy (ages 2–12), the first pharmacological option for this aggressive condition. Chemical Exposure: Experts warn PFAS “forever chemicals” may also enter the body through skin exposure, not just food and water, with possible links to immune, liver, and skin effects. Public Health in the Arctic: Nunavut health authorities suspect avian flu in 27 harvested birds near Iqaluit; they say human risk is low and recommend strict food-safety and handling precautions. Safe Abortion Access: Governments including Iceland reaffirm calls for safe, timely, affordable abortion care and warn restrictive laws increase harm. Health & Wellness in Iceland: Iceland’s geothermal heating remains a standout model—about 90% of homes rely on it—highlighting resilience lessons as energy prices and geopolitics stay in focus.

EU rare-disease breakthrough: The European Commission has granted marketing authorisation for Nezglyal (leriglitazone) under exceptional circumstances as the first EU pharmacological option for early intervention in male childhood cerebral adrenoleukodystrophy (cALD) ages 2–12 with Gd-negative brain lesions, aiming to halt irreversible neurodegeneration earlier than stem-cell transplant. Public health risk reminder: A University of Iceland toxicologist says PFAS “forever chemicals” may also enter the body through skin, not just food and water, raising concerns for immune, liver and skin effects. MS community push: Oculis is partnering with the National Multiple Sclerosis Society on its Campaign to End MS, focusing on vision and accelerating research and access to care. Care access & eligibility: The UK published guidance on indefinite leave to remain for bereaved foreign nationals, including requirements tied to the deceased partner’s status and the applicant’s visa history. Workforce strain in healthcare: Ireland plans to temporarily relax the 50:50 non-EEA hiring rule to ease staffing shortages in nursing homes, home-care and disability services. Health equity message: Governments including Iceland backed a statement for International Safe Abortion Day, urging access to safe, timely and affordable abortion care.

Neuro-ophthalmology biotech update: Oculis said director Lionel Carnot is resigning from its board, effective immediately, as the company moves into its next growth stage—an item worth watching for patients and investors in eye and brain-related sight disorders. Safe abortion access: Denmark, Estonia, Finland, France, Iceland and others backed International Safe Abortion Day with a call for laws that enable safe, timely, affordable care and warn restrictive rules raise maternal harm. HIV and aging care shift: A new look at “aging with HIV” highlights how modern ART is changing needs, with older patients facing more chronic conditions and requiring more targeted, age-aware care. Healthcare staffing pressure: Ireland plans to relax the “50:50 rule” limiting non-EEA workers to tackle shortages in nursing homes, home-care and disability services. Wound care innovation from Iceland-linked biotech: Kerecis launched “Compact,” a new fish-skin platform designed to reduce waste and simplify application for deep wounds. Longevity science angle: A roundup on extremely long-lived species—including an Iceland-named ocean clam and “immortal jellyfish”—spotlights what researchers hope to learn about aging and disease resistance.

Healthcare Workforce: Ireland is temporarily relaxing the “50:50 rule” that limits non-EEA workers to half of a healthcare employer’s staff, aiming to ease shortages in nursing homes, home-care and disability services. Rare Disease Treatment: The European Commission granted marketing authorization for Neuren’s Rett syndrome therapy (trofinetide/DAYBU), with coverage including Iceland, Norway and Liechtenstein—opening a new chapter for access to a first-in-class option. Wound Care Innovation: Kerecis launched “Compact,” a compressed fish-skin platform designed to reduce waste and make deep-wound application easier, targeting complex defects and irregular wound shapes. Mental Health & Therapy: Equine-assisted psychotherapy may help clinicians too, with research and practitioner interviews describing “horse time” as a way to stay present and reduce therapist stress. Public Health & Aging: New discussion highlights how HIV care needs are changing as people with HIV live longer, with age-related conditions and chronic inflammation reshaping clinical priorities. Digital Wellbeing: A new book argues screen-based social life can weaken empathy and human connection, pointing to brain and social effects of reduced face-to-face interaction. Community Health & Access: A Safe Abortion Day statement from multiple European governments—including Iceland—urges laws that protect access to safe, timely abortion care. Health Tech Funding (Europe): A weekly roundup reports major European healthtech investment, with AI and healthtech among the top funded sectors.

Safe Abortion Day Statement: Denmark, Estonia, Finland, Iceland and others backed International Safe Abortion Day with a call for laws that protect access to safe, timely and affordable abortion care, warning restrictive rules raise maternal harm and violate rights. Healthcare Staffing Pressure: Ireland is set to relax the “50:50 rule” that limits non-EEA workers in healthcare, aiming to ease shortages in nursing homes, home-care and disability services while training more staff. Rare Disease Treatment in Europe: The European Commission granted marketing authorization for NEZGLYAL® (leriglitazone), the first pharmacological treatment for cerebral adrenoleukodystrophy (cALD), a rare neurodegenerative condition. Wound Care Innovation (Iceland-linked company): Kerecis launched Compact, a new fish-skin platform designed to reduce waste and simplify application for deep wound defects, including tunneling and irregular geometries. Mental Health & Caregiving Trends: A report highlights equine-assisted psychotherapy helping not only patients but also therapists by improving presence and reducing stress. Digital Life & Loneliness: Researchers warn that screen-based communication can weaken empathy and social connection, reshaping how people relate. Local Health & Safety: A boy was injured by a discarded syringe at a Reykjavík elementary school, raising concerns about community safety. Health-Adjacent Society: A new happiness ranking puts Iceland second in the World Happiness Report, while Europe leads on closing the gender gap in health and survival.

Healthcare Staffing: Ireland is temporarily relaxing the “50:50 rule” limiting non-EEA workers to half of a healthcare workforce to ease critical staff shortages, especially in nursing homes, home-care and disability services. Rare Disease Treatment: The European Commission granted marketing authorization for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved in the EU for childhood cerebral adrenoleukodystrophy (cALD) in eligible patients. Wound Care Innovation: Kerecis launched Compact, a new compressed fish-skin platform designed to reduce waste and simplify handling for deep wounds and irregular wound shapes. Mental Health & Therapy Practice: Equine-assisted psychotherapy is being highlighted for helping not just patients but also therapists stay present and regulate stress during sessions. Digital Wellbeing: A new book argues that heavy screen-based social life can weaken face-to-face connection and empathy, with researchers pointing to brain and bonding differences. Local Health Safety: A boy was injured by a discarded syringe at a Reykjavík elementary school, raising concerns about community safety and prevention. Health-Adjacent Wellness: A “Disgusting Food Museum” opens in Hong Kong featuring Iceland’s hákarl among other unusual foods—more culture than care, but still a wellness-travel talking point.

New treatment for rare brain disease: The European Commission has granted marketing authorization for NEZGLYAL® (leriglitazone) for male cerebral adrenoleukodystrophy (cALD) patients aged 2–12 with Gd-negative brain lesions, the first pharmacological option approved in the EU, with an expected first launch in Germany by year-end. Wound-healing innovation: Kerecis launched Compact, a new compressed fish-skin platform designed to reduce waste and simplify application for deep, tunneling, and irregular wound defects. Mental health and care practice: A report on equine-assisted psychotherapy highlights how working with horses can help both patients and therapists by improving presence, emotional regulation, and stress reduction. Digital life and loneliness: Researchers warn that heavy screen-based socializing can weaken empathy and real-world connection, with face-to-face interaction linked to stronger brain synchrony. Public health watch: Iceland’s wider Nordic context includes renewed concern from health officials about energy drink use among teenagers. Local safety note: A boy was injured by a discarded syringe at a Reykjavík elementary school, raising urgent questions about safe disposal and prevention.

New treatment for rare brain disease: The European Commission granted marketing authorization for NEZGLYAL® (leriglitazone) for male cerebral adrenoleukodystrophy (cALD) patients aged 2–12 with Gd-negative brain lesions, the first pharmacological option in the EU for early intervention. Mental health practice insight: A new report highlights how equine-assisted psychotherapy may help not just patients but also therapists, with horses encouraging clinicians to stay more present and emotionally regulated. Screen use and loneliness: Researchers warn that heavy digital screen use can reshape social life and reduce face-to-face connection, potentially increasing loneliness. Gender gap data: Europe is again leading on closing the global gender gap, with near parity in education and health and survival—but full equality is still decades away. Health-linked community event: A large Pink Power Run 3.0 in Hyderabad drew about 35,000 people for breast cancer awareness, prevention and early detection. Iceland angle in global news: Iceland is mentioned in multiple international health and wellness contexts, including happiness rankings and conservation-related programming.

Rare disease drug approval: The European Commission has granted marketing authorization for NEZGLYAL® (leriglitazone) for childhood cerebral adrenoleukodystrophy (cALD) in male patients aged 2–12 with Gd-negative brain lesions—the first pharmacological option approved in the EU, with launches expected in Germany by year-end. Health security alert: Researchers say a new ransomware operation called Galago is emerging with claimed links to Panzer, after monitoring an Iceland-related healthcare organization claim—raising concerns for hospitals and clinics even before any confirmed victim list is published. Local health incident: A boy was injured by a discarded syringe at a Reykjavík elementary school, highlighting ongoing public safety and harm-reduction needs around sharps. Wellbeing & prevention: A large Pink Power Run 3.0 in Hyderabad drew about 35,000 people for breast cancer awareness, emphasizing prevention and early detection. Health innovation diplomacy: Minnesota Gov. Tim Walz’s trade mission to Denmark, Sweden and Iceland spotlights partnerships in healthcare innovation alongside clean tech and agriculture.

New Treatment for Rare Brain Disease: The European Commission has granted marketing authorization for NEZGLYAL® (leriglitazone) for male cerebral adrenoleukodystrophy (cALD) patients aged 2–12 with Gadolinium-negative brain lesions—described as the first pharmacological option for early intervention in the EU. Health & Safety in Schools: A boy was injured by a discarded syringe at Reykjavík Elementary School, renewing attention on safe disposal and prevention. Mental Wellbeing & Community: A new employee spotlight highlights Domestic Violence Awareness Month work in Iceland’s wider community context, focusing on prevention, survivor support, and accountability. Public Health Data & Risk: Nordic health officials sound the alarm over energy drink dependency among Swedish teenagers, pointing to growing concerns about youth consumption. Health, Climate & Resilience: UN-backed efforts to expand global ocean observation were launched at the UN General Assembly, linking better monitoring to safer navigation, weather forecasting, and coastal resilience. Wellbeing Rankings: Iceland ranks second in the World Happiness Report 2025, with Finland first—useful context for how quality of life is measured over multiple years.